Endomag Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 144

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $310M

Endomag General Information

Description

Developer of a magnetic sensing technology designed to improve the global standard of cancer care. The company's technology offers minimally invasive surgical guidance to ensure cancer can be targeted and removed more accurately through magnetic sensing for tumor identification and detection, enabling physicians to carry out tumor localizations and breast cancer staging with one platform.

Contact Information

Website
www.endomag.com
Formerly Known As
Endomagnetics
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Parent Company
Hologic
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 330 Cambridge Science Park
  • Milton Road
  • Cambridge CB4 0WN
  • England, United Kingdom
+44 01223

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Endomag Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 24-Jul-2024 $310M Completed Generating Revenue
11. Secondary Transaction - Private 01-Jun-2021 Completed Generating Revenue
10. Later Stage VC (Series D) 30-Nov-2020 Completed Generating Revenue
9. Later Stage VC (Series C) 23-Jul-2018 Completed Generating Revenue
8. Later Stage VC 28-Feb-2017 Completed Generating Revenue
7. Later Stage VC 19-Nov-2014 Completed Generating Revenue
6. Later Stage VC (Series B) 09-Aug-2013 Completed Generating Revenue
5. Early Stage VC (Series A) 11-Nov-2011 Completed Generating Revenue
4. Early Stage VC 09-Sep-2010 $543K $1.12M Completed Generating Revenue
3. Seed Round 01-Aug-2009 $578K $578K Completed Generating Revenue
To view Endomag’s complete valuation and funding history, request access »

Endomag Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
C2 Preferred
C1 Preferred
C2 Preferred
C1 Preferred
Preferred B
Ordinary
Ordinary
Preference
Preference 1,397,000 $0.001320 $1.32 $1.32 $1.32 7.48%
Preference 160,400 $0.001320 $0.83 $0.83 $0.83 0.86%
To view Endomag’s complete cap table history, request access »

Endomag Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a magnetic sensing technology designed to improve the global standard of cancer care. The company's technol
Diagnostic Equipment
Cambridge, United Kingdom
144 As of 2024

Rehovot, Israel
 

Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Endomag Competitors (14)

One of Endomag’s 14 competitors is ClearCut Medical, a Venture Capital-Backed company based in Rehovot, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ClearCut Medical Venture Capital-Backed Rehovot, Israel
Novian Health Venture Capital-Backed Chicago, IL
UE LifeSciences Venture Capital-Backed Philadelphia, PA
Asuragen Formerly VC-backed Austin, TX
Avelas Biosciences Venture Capital-Backed San Diego, CA
You’re viewing 5 of 14 competitors. Get the full list »

Endomag Patents

  • 201

    Total Documents Applications and Grants

  • Total Patents Families

  • 149

    Granted

  • 32

    Pending

  • Expiring in next 12 mo

Endomag Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240402269-A1 Magnetic probe apparatus Pending 08-Aug-2024
GB-202316925-D0 Improvements in and relating to the manufacture of handheld jointed instruments Pending 03-Nov-2023
GB-202204999-D0 Improvements in or relating to susceptibility probes for detecing surgical markers Active 05-Apr-2022
GB-202204998-D0 Improvements in or relating to susceptibility probes for detecting surgical markers Active 05-Apr-2022
GB-2617357-A8 Improvements in or relating to susceptibility probes for detecting surgical markers Active 05-Apr-2022 G01R33/0017
To view Endomag’s complete patent history, request access »

Endomag Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endomag Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bloomsbury Bioseed Fund Venture Capital Minority
Innovate UK Accelerator/Incubator
Molten Ventures Venture Capital Minority
New Wave Ventures Venture Capital Minority
Sarum Partners Limited Partner Minority
You’re viewing 5 of 7 investors. Get the full list »

Endomag Acquisitions (1)

Endomag’s most recent deal was a Merger/Acquisition with Actium Biosystem. The deal was made on 24-Jun-2014.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Actium Biosystem 24-Jun-2014 Merger/Acquisition Laboratory Services (Healthcare)
To view Endomag’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Endomag FAQs

  • When was Endomag founded?

    Endomag was founded in 2007.

  • Where is Endomag headquartered?

    Endomag is headquartered in Cambridge, United Kingdom.

  • What is the size of Endomag?

    Endomag has 144 total employees.

  • What industry is Endomag in?

    Endomag’s primary industry is Diagnostic Equipment.

  • Is Endomag a private or public company?

    Endomag is a Private company.

  • What is the current valuation of Endomag?

    The current valuation of Endomag is .

  • What is Endomag’s current revenue?

    The current revenue for Endomag is .

  • How much funding has Endomag raised over time?

    Endomag has raised $43.8M.

  • Who are Endomag’s investors?

    Bloomsbury Bioseed Fund, Innovate UK, Molten Ventures, New Wave Ventures, and Sarum Partners are 5 of 7 investors who have invested in Endomag.

  • Who are Endomag’s competitors?

    ClearCut Medical, Novian Health, UE LifeSciences, Asuragen, and Avelas Biosciences are some of the 14 competitors of Endomag.

  • When was Endomag acquired?

    Endomag was acquired on 24-Jul-2024.

  • Who acquired Endomag?

    Endomag was acquired by Hologic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »